Launch of the European Drug Report 2022: Trends and Developments

The EMCDDA will be launching its European Drug Report 2022: Trends and Developments in a live virtual press conference on 14 June. Based on data from 29 countries (EU 27, Turkey and Norway), the report will deliver the latest overview of the drug situation in Europe. The publication, to be available in 25 languages, is an essential resource for developing evidence-based policies and responses. Accompanying the report will be the 2022 Statistical Bulletin and an update on new psychoactive substances in Europe. Further details on how to register will be available soon on our website.